Skip to main content
SpringerLink
Log in
Book cover

Genitourinary Pathology pp 231–234Cite as

Familial Urothelial Carcinomas

  • Chapter
  • First Online:

  • 1659 Accesses

Abstract

Some urothelial carcinomas have a hereditary basis; in some cases due to as yet unknown genetic mechanisms and in others due to established genetic syndromes (e.g., Lynch syndrome). This chapter summarizes what is currently known about hereditary urothelial carcinomas, their genetic bases, relevant morphologic details, and familial implications.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Grotenhuis AJ, Vermeulen SH, Kiemeney LA. Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response. Future Oncol. 2010;6:1433–60.

    Article  CAS  PubMed  Google Scholar 

  2. Garcia-Closas M, Malats N, Silverman D, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet. 2005;366:649–59.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Audenet F, Colin P, Yates DR, et al. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool. BJU Int. 2012;110:E583–9.

    Article  PubMed  Google Scholar 

  4. Hollande C, Colin P, de La Motte Rouge T, et al. Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours. BJU Int. 2014;113(4):574–80.

    Article  CAS  PubMed  Google Scholar 

  5. Mueller CM, Caporaso N, Greene MH. Familial and genetic risk of transitional cell carcinoma of the urinary tract. Urol Oncol. 2008;26:451–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Kantor AF, Hartge P, Hoover RN, et al. Familial and environmental interactions in bladder cancer risk. Int J Cancer. 1985;35:703–6.

    Article  CAS  PubMed  Google Scholar 

  7. Aben KK, Witjes JA, Schoenberg MP, et al. Familial aggregation of urothelial cell carcinoma. Int J Cancer. 2002;98:274–8.

    Article  CAS  PubMed  Google Scholar 

  8. Skeldon SC, Semotiuk K, Aronson M, et al. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. Eur Urol. 2013;63:379–85.

    Article  CAS  PubMed  Google Scholar 

  9. Hartmann A, Cheville JC, Dietmaier W, et al. Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract. Arch Pathol Lab Med. 2003;127:E60–63.

    PubMed  Google Scholar 

  10. Maul JS, Warner NR, Kuwada SK, et al. Extracolonic cancers associated with hereditary nonpolyposis colorectal cancer in the Utah Population Database. Am J Gastroenterol. 2006;101:1591–96.

    Article  PubMed  Google Scholar 

  11. Crockett DG, Wagner DG, Holmang S, et al. Upper urinary tract carcinoma in Lynch syndrome cases. J Urolo. 2011;185:1627–30.

    Article  Google Scholar 

  12. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer. 1993;71:677–85.

    Article  CAS  PubMed  Google Scholar 

  13. Watson P, Vasen HF, Mecklin JP, et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer. 2008;123:444–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Watson P, Lynch HT. The tumor spectrum in HNPCC. Anticancer Res. 1994;14:1635–9.

    CAS  PubMed  Google Scholar 

  15. Hartmann A, Dietmaier W, Hofstadter F, et al. Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability. Hum Pathol. 2003;34:222–7.

    Article  PubMed  Google Scholar 

  16. Mongiat-Artus P, Miquel C, Flejou JF, et al. Spectrum of molecular alterations in colorectal, upper urinary tract, endocervical, and renal carcinomas arising in a patient with hereditary non-polyposis colorectal cancer. Virchows Arch. 2006;449:238–43.

    Article  PubMed  Google Scholar 

  17. Bonnal C, Ravery V, Toublanc M, et al. Absence of microsatellite instability in transitional cell carcinoma of the bladder. Urology. 2000;55:287–91.

    Article  CAS  PubMed  Google Scholar 

  18. van der Post RS, Kiemeney LA, Ligtenberg MJ, et al. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. J Med Genet. 2010;47:464–70.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Fletcher O, Easton D, Anderson K, et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst. 2004;96:357–63.

    Article  PubMed  Google Scholar 

  20. Marees T, Moll AC, Imhof SM, et al. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst. 2008;100:1771–9.

    Article  PubMed  Google Scholar 

  21. Mitra AP, Birkhahn M, Cote RJ. p53 and retinoblastoma pathways in bladder cancer. World J Urol. 2007;25:563–71.

    Article  CAS  PubMed  Google Scholar 

  22. Franceschini P, Licata D, Di Cara G, et al. Bladder carcinoma in Costello syndrome: report on a patient born to consanguineous parents and review. Am J Med Genet. 1999;86:174–79.

    Article  CAS  PubMed  Google Scholar 

  23. Gripp KW, Scott CI Jr., Nicholson L, et al. Second case of bladder carcinoma in a patient with Costello syndrome. Am J Medal Genet. 2000;90(3):256–9.

    Article  CAS  Google Scholar 

  24. Urakami S, Igawa M, Shiina H, et al. Recurrent transitional cell carcinoma in a child with the Costello syndrome. J Urol. 2002;168:1133–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Cleveland Clinic, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland, OH, USA

    Asst. Prof. Christopher G. Przybycin & Jesse K. McKenney MD

Authors
  1. Asst. Prof. Christopher G. Przybycin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jesse K. McKenney MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher G. Przybycin .

Editor information

Editors and Affiliations

  1. Department of Pathology, The Cleveland Clinic, Cleveland, Ohio, USA

    Cristina Magi-Galluzzi

  2. Department of Pathology, The Cleveland Clinic, Cleveland, Ohio, USA

    Christopher G. Przybycin

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Przybycin, C., McKenney, J. (2015). Familial Urothelial Carcinomas. In: Magi-Galluzzi, C., Przybycin, C. (eds) Genitourinary Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2044-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2044-0_17

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2043-3

  • Online ISBN: 978-1-4939-2044-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation